⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10414012 | 1.00 | — | — | |
| SCHEMBL28242531 | 0.78 | — | — | |
| SCHEMBL16554046 | 0.75 | — | — | |
| SCHEMBL3153854 | 0.70 | — | — | |
| Phosphoric Acid SCHEMBL27699326 | 0.70 | — | — | |
| Phosphoric Acid SCHEMBL15312963 | 0.68 | CA2 (0.50) | — | |
| Phosphoric Acid SCHEMBL2092954 | 0.68 | CA2 (0.50) | — | |
| Phosphoric Acid SCHEMBL107716 | 0.68 | — | — | |
| Phosphoric Acid SCHEMBL2815522 | 0.68 | CA2 (0.50) | — | |
| Phosphoric Acid SCHEMBL6244258 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4224 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12378267-B2 | Synthesis of FMOC-protected morpholino monomers and oligomers | ENTRADA THERAPEUTICS, INC. (US) | 2025-08-05 | — | — | US | claimed |
| US-20240238282-A1 | METHODS OF TREATING CANCER AND ISCHEMIA DISEASES BY INHIBITION AND INTERVENTION OF ATR PROLYL ISOMERIZATION | THE UNIVERSITY OF TOLEDO (US) | 2024-07-18 | — | — | US | claimed |
| US-12012427-B2 | Synthesis of Fmoc-protected morpholino monomers and their use in the synthesis of morpholino oligomer | INDIAN ASSOCIATION FOR THE CULTIVATION OF SCIENCE (IN) | 2024-06-18 | — | — | US | claimed |
| CN-114957364-B | Iodine base, preparation method thereof and constructed amphiphilic nucleic acid | 湖南大学 | 2024-01-23 | — | — | CN | claimed |
| US-20230097585-A1 | SYNTHESIS OF FMOC-PROTECTED MORPHOLINO MONOMERS AND OLIGOMERS | ENTRADA THERAPEUTICS, INC. | 2023-03-30 | — | — | US | claimed |
| CN-113754694-B | Method for synthesizing Reidesvir by asymmetric catalysis of non-protecting group nucleoside | 上海交通大学 | 2022-10-25 | — | — | CN | claimed |
| CN-113747947-A | Combination therapy | 沙塔克实验室有限公司 | 2021-12-03 | — | — | CN | claimed |
| CN-113727722-A | Bacterial membrane preparation | 伊夫罗生物科学公司 | 2021-11-30 | — | — | CN | claimed |
| CN-113727734-A | Ligand-drug conjugates comprising a linker having a tris structure | 乐高化学生物科学股份有限公司 | 2021-11-30 | — | — | CN | claimed |
| CN-113599533-A | Antibody-drug conjugates comprising branched linkers and methods related thereto | 乐高化学生物科学股份有限公司 | 2021-11-05 | — | — | CN | claimed |
| US-8846681-B2 | Pyrimidyl cyclopentanes as AKT protein kinase inhibitors | ARRAY BIOPHARMA, INC. (US) | 2014-09-30 | — | — | US | claimed |
| US-20130261104-A1 | METHODS OF USE OF DIAZACARBAZOLES FOR TREATING CANCER | GENENTECH, INC. (US) | 2013-10-03 | — | — | US | claimed |
| EP-2402325-A2 | Hydroxylated and methoxylated cyclopenta[d]pyrimidines as AKT protein kinase inhibitors | Array Biopharma, Inc. (US) | 2012-01-04 | — | — | EP | claimed |
| US-8076476-B2 | Synthesis of morpholino oligomers using doubly protected guanine morpholino subunits | AVI BIOPHARMA, INC. (US) | 2011-12-13 | — | — | US | claimed |
| US-20110245230-A1 | PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS | ARRAY BIOPHARMA INC. (US) | 2011-10-06 | — | — | US | claimed |
| EP-2207779-A1 | METHOD OF SYNTHESIS OF MORPHOLINO OLIGOMERS | Avi Biopharma, Inc. (US) | 2010-07-21 | — | — | EP | claimed |
| WO-2009064471-A1 | METHOD OF SYNTHESIS OF MORPHOLINO OLIGOMERS | AVI BIOPHARMA, INC. (US) | 2009-05-22 | — | — | WO | claimed |
| US-20090131624-A1 | SYNTHESIS OF MORPHOLINO OLIGOMERS USING DOUBLY PROTECTED GUANINE MORPHOLINO SUBUNITS | AVI BIOPHARMA, INC. (US) | 2009-05-21 | — | — | US | claimed |
| EP-1468007-A2 | PSEUDONUCLEOTIDE COMPRISING AN INTERCALATOR | Human Genetic Signatures PTY Ltd. (AU) | 2004-10-20 | — | — | EP | claimed |
| WO-2003051901-A2 | PSEUDONUCLEOTIDE COMPRISING AN INTERCALATOR | HUMAN GENETIC SIGNATURES PTY LTD (AU) | 2003-06-26 | — | — | WO | claimed |